PMI considers restarting production in Ukraine

May.24.2023
PMI considers restarting production in Ukraine
Philip Morris International considers restarting production in Ukraine despite security concerns and decreased sales.

In a recent interview with Interfax Ukraine, Massimo Andolina, the European Regional President of Philip Morris International (PMI), discussed the impact of Russia's invasion on multinational corporations in Ukraine. Andolina stated that PMI is exploring plans to restore production in Ukraine.


PMI has ceased production at its factory in Kharkiv due to ongoing security concerns resulting from the ongoing conflict. Currently, the company's brands in Ukraine are being temporarily produced by Imperial Tobacco. However, PMI intends to establish its own production facility in Ukraine.


Maximo Andolina emphasized two reasons for the decision: first, the desire to produce PMI's own products locally, and secondly, the company's commitment to investing in Ukraine even during times of war. He stated that PMI is actively exploring various alternative options for establishing new production facilities and plans to make relevant announcements in the near future.


The interview also touched on the decrease in PMI sales in the Ukrainian market. Massimo Andolina mentioned two factors: some people leaving the country or residing in occupied territory, resulting in consumer loss, and competition from illegal products. He stated that PMI has discussed with the government to address this issue and expressed confidence in the government's commitment to combating corruption and criminal activity. The company expects significant progress in combating illegal trade in the coming years.


Maximo Adonilna also shared his opinion on the government's decision to tax cigarettes and heated non-burning products. He stated that PMI believes these products should be considered different categories and taxed accordingly. They have noticed the success of heated tobacco products in the Ukrainian market and emphasized the necessity for differentiated tax treatment.


During the interview, the position of PMI in Russia was also addressed. According to Massimo Andolina, the company's top priority during the war was the protection of its Ukrainian employees' safety. Therefore, they temporarily suspended their investments in Russia and reduced their business operations. Despite PMI's previous announcement of its intention to withdraw from the Russian market, the changing regulatory environment has made it challenging for the company, which has significant business and assets in the country, to do so.


Reference List:


PMI is considering restarting production in Ukraine.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Research Summary | NHANES Study: Smoking or E-Cigarette Use Linked to Higher Prevalence of Elevated Blood Pressure and Hypertension
Research Summary | NHANES Study: Smoking or E-Cigarette Use Linked to Higher Prevalence of Elevated Blood Pressure and Hypertension
A cross-sectional analysis based on the US NHANES 2021–2023 cycle, including 6,262 participants aged over 12, found that compared with people who neither smoke nor vape, those who smoke and/or use e-cigarettes had a higher prevalence of elevated blood pressure and hypertension. After full adjustment, smoking/vaping was associated with elevated blood pressure (aOR 1.34) and hypertension (aOR 1.46), and with a 1.05 mmHg higher diastolic blood pressure.
Feb.09 by 2FIRSTS.ai
BAT says a U.S. import block on some disposable vapes could cut illegal sales by about a third
BAT says a U.S. import block on some disposable vapes could cut illegal sales by about a third
Reuters reported that British American Tobacco (BAT) CEO Tadeu Marroco said a potential U.S. move to block imports of some disposable vapes could reduce the market for unregulated e-cigarettes by as much as a third, though any impact is unlikely before 2027.
Feb.13 by 2FIRSTS.ai
U.S. FDA Posts Final ZYN MRTP Materials, Sets March 4 Deadline for Public Comments
U.S. FDA Posts Final ZYN MRTP Materials, Sets March 4 Deadline for Public Comments
U.S. FDA has released the final batch of materials for ZYN MRTP applications and set March 4 (11:59 p.m. ET) as the deadline for public comments to be considered in the agency’s review.
Feb.03 by 2FIRSTS.ai
Netherlands plans to raise nicotine purchase age to 21, including vapes
Netherlands plans to raise nicotine purchase age to 21, including vapes
The Netherlands is planning to raise the legal age for buying nicotine-containing products from 18 to 21, a change that would also cover vapes. The move, embedded in the governing coalition’s latest agreement, aligns with a wider European trend toward tighter youth nicotine controls, though industry groups have criticised the proposal and warned it could fuel illicit trade.
Feb.09 by 2FIRSTS.ai
Australia: NSW police and ABF seize illicit tobacco and vapes worth over A$1.6 million in Sydney’s southwest
Australia: NSW police and ABF seize illicit tobacco and vapes worth over A$1.6 million in Sydney’s southwest
In Australia’s New South Wales, a joint operation in Sydney’s southwest led to the seizure of illicit tobacco and vape products valued at over A$1.6 million (about US$1.09 million) from a warehouse in Riverwood.
Jan.22 by 2FIRSTS.ai
Special Report | Breeze and Glas Seek White House Review as FDA Advances Flavored ENDS Guidance
Special Report | Breeze and Glas Seek White House Review as FDA Advances Flavored ENDS Guidance
Breeze Smoke and Glas, Inc. have separately requested White House review under Executive Order 12866 as the FDA advances draft guidance on flavored ENDS (RIN 0910-ZC78). The guidance aims to clarify evidentiary standards under the statutory “appropriate for the protection of public health” (APPH) framework. The parallel filings highlight industry concern over regulatory predictability, particularly as Glas’s PMTA review status has recently drawn market attention.
Special Report
Mar.03